🇺🇸 FDA
Patent

US 12209180

Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as LXR agonists

granted A61KA61K47/6803A61K47/6849

Quick answer

US patent 12209180 (Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as LXR agonists) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
45
CPC classes
A61K, A61K47/6803, A61K47/6849, A61K47/6883, A61K47/6889